Correspondence to editorial on “Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer”
Clinical and Molecular Hepatology · 06.11.2026
DOI: 10.3350/cmh.2026.0255 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Daeseong Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
- Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- Department of Life Science, CHA University, Seongnam, Korea.
- Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea. minidoctor@cha.ac.kr.
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. inspector@yuhs.ac.
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea. young0608@yuhs.ac.
Zitieren
APA
Kim, D., Sim, N. S., Woo, S., Chon, H. J., Kim, C. G., Park, Y. N., & Choi, H. J. (2026). Correspondence to editorial on “Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0255
Vancouver
Kim D, Sim NS, Woo S, Chon HJ, Kim CG, Park YN, et al. Correspondence to editorial on “Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0255
BibTeX
@article{Kim2026,
author = {Kim, Daeseong and Sim, Nam Suk and Woo, Seonjeong and Chon, Hong Jae and Kim, Chang Gon and Park, Young Nyun and Choi, Hye Jin},
title = {Correspondence to editorial on “Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0255}
}
EUVIMED